Tag: monoclonal antibody
IgGenix Secures $40M Funding to Advance Antibody Therapy to Treat Food...
IgGenix, a San Francisco-based biotech company, announced yesterday they had secured $40 million in Series B funding to bring a peanut allergy candidate to...
United Biopharma’s Monoclonal Antibody Shows Promise in Neutralizing IgE
Shows promise for the treatment of chronic spontaneous urticaria, food allergies, asthma and eczema.
IgGenix Shows Potential of Platform to Advance Understanding of Tree Nut...
The company is aiming at more targeted therapeutic approaches that have the potential to address key allergens directly.
FDA Approves Dupixent® as First Biologic for Treatment of Children Aged...
Three-quarters of patients receiving Dupixent achieved at least a 75% improvement in overall disease, with an average improvement of approximately 80%.
Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...
“In-licensing AIMab7195 demonstrates our commitment to enriching our pipeline and strengthening Aimmune’s global leadership in the evolving therapeutic landscape of food allergy treatments.”
Study: New Gene Therapy Protects Against Anaphylaxis from Peanut Allergy
The technique could also be applied to other IgE-mediated food allergies.
FARE Announces Grant for Promising Research
FARE has announced that it is providing over $700,000 to help fund promising research that may lead to a fast, effective treatment for food allergies.
